Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03431844
• Date of registration: 18/01/2018
• Prospective Registration: No
• Primary sponsor: University of Tartu
• Public title: Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation
• Scientific title: Prospective Clinical Observational Study of Humanin Isoforms in Cardiac Muscle and Blood Plasma and Their Association to Major Complications After Cardiac Operation
• Date of first enrolment: January 1, 2018
• Target sample size: 106
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03431844
• Study type: Observational

Countries of recruitment

Estonia

Contacts

• Name: Joel Starkopf, MD, PhD
• Affiliation: Tartu University Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Age at least 18 years

- Ischemic heart disease in medical history

- Planned on-pump coronary artery bypass graft (CABG) operation

- Signed informed consent by patient

Exclusion Criteria:

- Age <18 years

- Planned isolate valve or aortic operation

- Patient is in another study with an intervention

- Absence of signed informed consent



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Coronary Artery Bypass Surgery

Myocardial Ischemia

Primary Outcome(s)

Major complications: stroke. [Time Frame: 30 days]

Major complications: acute kidney injury. [Time Frame: 30 days]

Mortality [Time Frame: 30 days]

Major complications: myocardial infarction. [Time Frame: 30 days]

Secondary ID(s)

HN1160

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

North Estonia Medical Centre

Tartu University Hospital